Skip to content
10-K

Annual Report

RENNOVA HEALTH, INC.

0001493152-25-006522

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Feb 4, 2025 43.05B sh
Shares Diluted FY 2023 · Dec 31, 2023 32.83B sh
Shares Diluted FY 2023 · Dec 31, 2022 9.99B sh
Operating Cash Flow FY 2023 · Dec 31, 2023 $3.39M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$218.35K
Long Term Debt FY 2023 · Dec 31, 2023 $8.22M
Cash And Equivalents FY 2023 · Dec 31, 2023 $49.02K
Cash And Equivalents FY 2023 · Dec 31, 2022 $499.47K
Stockholders Equity FY 2023 · Dec 31, 2023 −$36.82M
Stockholders Equity FY 2023 · Dec 31, 2022 −$29.09M
Current Liabilities FY 2023 · Dec 31, 2023 $42.51M
Current Liabilities FY 2023 · Dec 31, 2022 $49.31M
Total Liabilities FY 2023 · Dec 31, 2023 $57.1M
Total Liabilities FY 2023 · Dec 31, 2022 $49.67M
Current Assets FY 2023 · Dec 31, 2023 $6.94M
Current Assets FY 2023 · Dec 31, 2022 $6.36M
Total Assets FY 2023 · Dec 31, 2023 $20.25M
Total Assets FY 2023 · Dec 31, 2022 $20.57M
Eps Diluted FY 2023 · Dec 31, 2023 $0.00
Eps Diluted FY 2023 · Dec 31, 2022 −$0.03
Eps Basic FY 2023 · Dec 31, 2023 $0.00
Eps Basic FY 2023 · Dec 31, 2022 −$0.03
Sga Expense FY 2023 · Dec 31, 2023 $9.44M
Sga Expense restated FY 2023 · Dec 31, 2022 $7.22M
Net Income FY 2023 · Dec 31, 2023 −$7.73M
Net Income FY 2023 · Dec 31, 2022 −$3.29M
Operating Income FY 2023 · Dec 31, 2023 $1.37M
Operating Income restated FY 2023 · Dec 31, 2022 −$1.42M
Revenue FY 2023 · Dec 31, 2023 $18.69M
Revenue FY 2023 · Dec 31, 2022 $13.04M
Short Term Debt FY 2023 · Dec 31, 2022 $8.62M